DE602006012346D1 - Pharmazeutische zusammensetzungen mit kontrollierter freisetzung für säurelabile arzneimittel - Google Patents

Pharmazeutische zusammensetzungen mit kontrollierter freisetzung für säurelabile arzneimittel

Info

Publication number
DE602006012346D1
DE602006012346D1 DE602006012346T DE602006012346T DE602006012346D1 DE 602006012346 D1 DE602006012346 D1 DE 602006012346D1 DE 602006012346 T DE602006012346 T DE 602006012346T DE 602006012346 T DE602006012346 T DE 602006012346T DE 602006012346 D1 DE602006012346 D1 DE 602006012346D1
Authority
DE
Germany
Prior art keywords
saeelelabile
pharmaceutical compositions
controlled release
medicinal products
medicinal
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
DE602006012346T
Other languages
English (en)
Inventor
George Shlieout
Claus-Juergen Koelln
Frithjof Sczesny
Jens Onken
Andreas Koerner
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Abbott Products GmbH
Original Assignee
Solvay Pharmaceuticals GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=37415587&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DE602006012346(D1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Solvay Pharmaceuticals GmbH filed Critical Solvay Pharmaceuticals GmbH
Priority claimed from PCT/EP2006/065311 external-priority patent/WO2007020259A2/en
Publication of DE602006012346D1 publication Critical patent/DE602006012346D1/de
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/282—Organic compounds, e.g. fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2813—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
    • A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5015—Organic compounds, e.g. fats, sugars
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5036—Polysaccharides, e.g. gums, alginate; Cyclodextrin
    • A61K9/5042—Cellulose; Cellulose derivatives, e.g. phthalate or acetate succinate esters of hydroxypropyl methylcellulose
DE602006012346T 2005-08-15 2006-08-15 Pharmazeutische zusammensetzungen mit kontrollierter freisetzung für säurelabile arzneimittel Active DE602006012346D1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US70869205P 2005-08-15 2005-08-15
EP05107472 2005-08-15
PCT/EP2006/065311 WO2007020259A2 (en) 2005-08-15 2006-08-15 Controlled release pharmaceutical compositions for acid labile drugs

Publications (1)

Publication Number Publication Date
DE602006012346D1 true DE602006012346D1 (de) 2010-04-01

Family

ID=37415587

Family Applications (1)

Application Number Title Priority Date Filing Date
DE602006012346T Active DE602006012346D1 (de) 2005-08-15 2006-08-15 Pharmazeutische zusammensetzungen mit kontrollierter freisetzung für säurelabile arzneimittel

Country Status (6)

Country Link
KR (1) KR101344546B1 (de)
DE (1) DE602006012346D1 (de)
HK (1) HK1121037A1 (de)
HR (1) HRP20100269T4 (de)
IL (1) IL189456A (de)
NO (1) NO342633B1 (de)

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2189698A (en) * 1986-04-30 1987-11-04 Haessle Ab Coated omeprazole tablets
JP3611456B2 (ja) * 1997-09-30 2005-01-19 日研化学株式会社 テオフィリン徐放性錠剤
KR19990072826A (ko) * 1998-02-26 1999-09-27 우재영 판크레아틴장용코팅과립의제조방법
IT1319655B1 (it) * 2000-11-15 2003-10-23 Eurand Int Microsfere di enzimi pancreatici con elevata stabilita' e relativometodo di preparazione.

Also Published As

Publication number Publication date
IL189456A (en) 2015-11-30
NO20081377L (no) 2008-05-14
KR20080034515A (ko) 2008-04-21
HRP20100269T4 (hr) 2017-06-30
IL189456A0 (en) 2008-06-05
HRP20100269T1 (en) 2010-06-30
KR101344546B1 (ko) 2013-12-26
HK1121037A1 (en) 2009-04-17
NO342633B1 (no) 2018-06-25

Similar Documents

Publication Publication Date Title
EP2130552A4 (de) Pharmazeutische zusammensetzung mit einem anti-grp78-antikörper als wirkstoff
IL185390A (en) A solid dosage form
EP2078731A4 (de) Anti-hb-egf-antikörper als wirkstoff enthaltende pharmazeutische zusammensetzung
DK1983964T3 (da) Anordning til indgivelse af lægemiddel
IL194460A0 (en) Deazapurine derivatives and pharmaceutical compositions containing the same
DK2073795T3 (da) Misbrugssikret lægemiddelformulation
BRPI0810928A2 (pt) "composição farmacêutica"
ATE493119T1 (de) Pharmazeutische zusammensetzung
BRPI0809667A2 (pt) Composto, medicamento e composição farmacêutica que o contém e uso do composto
ATE517619T1 (de) Stabilisierte pharmazeutische zusammensetzung mit fesoterodin
HUS1800034I1 (hu) Anti-FGF23 ellenanyag és anti-FGF23 ellenanyagot tartalmazó gyógyászati készítmény
EP2062579A4 (de) Feste pharmazeutische zusammensetzung zur oralen verabreichung mit optisch stabilem ramosetron
DE602008005137D1 (de) Chinolonverbindung und pharmazeutische zusammensetzung
ATE480227T1 (de) Pharmazeutische zusammensetzungen mit quetiapinfumarat
ZA200803152B (en) Oramucosal pharmaceutical dosage form
BRPI0821454A2 (pt) Formulação farmacêutica, excipiente para a preparação de formulação farmacêuticas de liberação lenta, e, processos para a produção de um excipiente de liberação lenta, e de uma forma farmacêutica.
BRPI0813937A2 (pt) Derivado de 17beta-ciano-19-nor-andros-4-eno, seu uso e medicamentos contendo o derivado
MX2008003644A (en) Particulate lipid pharmaceutical composition
DE602005007319D1 (de) Zubereitung zur kontinuierlichen Arzneimittelfreisetzung Chitosan enthaltend
DE602006012346D1 (de) Pharmazeutische zusammensetzungen mit kontrollierter freisetzung für säurelabile arzneimittel
GB0701295D0 (en) Z-stilbenes derivatives and the pharmaceutical composition thereof
UA13493S (uk) Упаковка для фармацевтичного препарату «німід»
UA11142S (uk) Упаковка для лікарського (фармацевтичного) засобу
UA11291S (uk) Упаковка для лікарського (фармацевтичного) засобу
UA11290S (uk) Упаковка для лікарського (фармацевтичного) засобу

Legal Events

Date Code Title Description
8363 Opposition against the patent